Beijing Daxiang Biotech | China's Organoids-on-Chips Leader

Select the model you are interested in

PRODUCT

SERVICE

01Organoids-On-Chips

We provide Organoids-On-Chips of various specifications for you to carry out in vitro model construction and related research

We provideOrganoids-On-Chips of various specifications for you to carry out in vitro model construction and related research

Organoids-On-Chips

02In vitro model

We provide a variety of single-organ, multi-organ and barrier models in vitro to meet your research needs

In vitro model

03Technical service

We provide pharmacological, toxicological and basic scientific research services based on a variety of innovative in vitro models

Technical service

CORE TECHNOLOGY

Organoids-on-Chips

IBAC®

The next-generation high-throughput, high-bionic in vitro model construction platform created by combining the two cutting-edge technologies of organoid and organ chip has a wide range of applications in new drug research and development, disease modeling and personalized precision medicine.

Da Xiang Biotech and Nikon signed a strategic cooperation agreement to jointly promote the development of organoid chip technology

On April 12, 2022, Daxiang Biotech and Nikon signed a strategic cooperation agreement .

Amendment of FDA Act, organ chip leading drug R&D reform

Organ chips and microphysiological systems were included in the bill for the first time as independent non-clinical experimental drug evaluation systems. Organ chips and cell models, computer modeling and animal models were regarded as equally important research tools.

Beijing Daxiang Biotech , together with Wuhan BioBank, will jointly build a standardized business model for organoids

Beijing Daxiang Biotech and Wuhan BioBank signed a strategic cooperation agreement, and the two sides will conduct in-depth cooperation in the joint construction of organ-like sample database, the development of organoids models